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TDP2 suppresses chromosomal translocations
induced by DNA topoisomerase II during gene
transcription
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DNA double-strand breaks (DSBs) induced by abortive topoisomerase II (TOP2) activity are
a potential source of genome instability and chromosome translocation. TOP2-induced DNA
double-strand breaks are rejoined in part by tyrosyl-DNA phosphodiesterase 2 (TDP2)-
dependent non-homologous end-joining (NHEJ), but whether this process suppresses or
promotes TOP2-induced translocations is unclear. Here, we show that TDP2 rejoins DSBs
induced during transcription-dependent TOP2 activity in breast cancer cells and at the
translocation ‘hotspot’, MLL. Moreover, we ﬁnd that TDP2 suppresses chromosome
rearrangements induced by TOP2 and reduces TOP2-induced chromosome translocations
that arise during gene transcription. Interestingly, however, we implicate TDP2-dependent
NHEJ in the formation of a rare subclass of translocations associated previously with therapy-
related leukemia and characterized by junction sequences with 4-bp of perfect homology.
Collectively, these data highlight the threat posed by TOP2-induced DSBs during transcrip-
tion and demonstrate the importance of TDP2-dependent non-homologous end-joining in
protecting both gene transcription and genome stability.
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T
umorigenesis is a multistage process that involves the
accumulation of genetic changes. Cytogenetic aberrations
are common features of neoplasia and have a key impact in
cancer development. Whereas gross chromosomal abnormalities
such as duplications, deletions, and chromosome loss or gain are
commonly involved in late stages of tumor development,
reciprocal translocations represent single events that contribute to
initial stages of cellular disarray. The molecular mechanisms
that underlie the formation of reciprocal translocations are
of great interest, because they can result chimeric proteins and/or
deregulated transcription programmes that can drive oncogenesis
in a variety of solid tumors and leukemias1–3. A number
of reciprocal translocations involve partner genes that are
co-located in a common transcription factory such as IgH and
myc in Burkitt´s lymphoma4, TMPRSS2 and ERG in prostate
cancer5, and mixed lineage leukemia (MLL), AF4 and AF9 in
leukemia6, 7. Consistent with the idea that spatial proximity is an
important factor in reciprocal translocation formation8, translo-
cations arise from DNA double-strand breaks (DSBs) arising in
nearby genes2. Nonetheless, the molecular mechanisms that
underlie DSB induction and gene fusion during the translocation
of actively transcribed genes are unclear and controversial.
Indeed, some studies suggest that DSBs that drive translocations
are obligate and/or are ‘programmed’ intermediates of some
transcription events9–12.
One class of enzymes implicated in DSB induction during gene
expression are DNA topoisomerases. Topoisomerases, are
enzymes that remove torsional stress in DNA by introducing
transient DNA breaks and are involved in a wide variety of
nuclear processes including transcription and DNA replication13.
Type II topoisomerases (e.g. TOP2) pass one DNA duplex
through another via a DSB intermediate known as the ‘cleavage
complex’; within which the topoisomerase has cleaved both
strands of DNA and is covalently linked to the 5′-terminus of the
DSB via a phosphotyrosyl bond14. The cleavage complex is
normally transient, because the topoisomerase reseals the break at
the end of its catalytic cycle. However, cleavage complexes are the
targets of a class of anti-tumor agents such as etoposide that act as
topoisomerase ‘poisons’, resulting in the formation of ‘abortive’
cleavage complexes that require removal by DSB repair.
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Fig. 1 TDP2 suppresses TOP2-induced genome instability in human cells. aMicronuclei (MN, left) and nucleoplasmic bridges (NB, right) were quantiﬁed in
control and TDP2 patient lymphoblastoid cells following continuous treatment (24 h) with the indicated concentration of etoposide. Data are the average
(±s.e.m.) of a minimum of 300 cells from three independent experiments. Statistical signiﬁcance was determined by T-test (*P< 0.05, **P< 0.01).
b M-FISH karyotyping of control and TDP2 patient lymphoblastoid cells following continuous treatment with 50 nM etoposide for 20 h. Left, example of a
patient metaphase depicting a chromatid break on Chr2 and a dicentric chromosome involving Chr3 and Chr4 (white asterisks). Right, quantiﬁcation of
abnormal metaphases by M-FISH in control and TDP2 patient lymphoblastoid cells. Statistical signiﬁcance was determined by GLM ANOVA (***P< 0.005,
NS, not signiﬁcant). c Distribution of chromosome aberrations per abnormal metaphase. The total number of events (chromosome and chromatid
exchanges/breaks) were counted in each abnormal metaphase (5 or more events per cell were pooled as > 5). Statistical signiﬁcance was determined by
ANOVA (*P< 0.05, ***P< 0.005)
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Fig. 2 TDP2 protects gene transcription from TOP2-induced DSBs. a Clonogenic survival of wild-type and TDP2−/− RPE-1 cells following treatment (3 h) with
the indicated concentrations of etoposide. Data are the mean (±s.e.m.) of three independent experiments. Statistical signiﬁcance was determined by
two-way ANOVA (*P< 0.05, **P< 0.01, ***P< 0.005). Molecular weight markers are in KDa. b The number of γH2AX foci in wild-type and TDP2−/− RPE-1
cells before and 30min after treatment with 20 µM etoposide, and after the indicated repair periods in drug-free medium. Data are the mean (± s.e.m.) of at
least three independent experiments. Statistical signiﬁcance was determined by T-tests (*P< 0.05, **P< 0.01, ***P< 0.005). c The number of γH2AX foci in
serum-starved wild-type and TDP2−/− RPE-1 cells was measured following treatment with 5 µM etoposide. Where indicated, cells were pre-incubated with
the transcription inhibitor DRB (100 µM) for 3 h prior to etoposide treatment. Other details are as in b. d Clonogenic survival of mock-depleted (shControl)
or TDP2-depleted (shTDP2) MCF7 cells following treatment (3 h) with the indicated concentrations of etoposide. Other details are as in a. e The number of
γH2AX foci in mock-depleted (shControl) or TDP2-depleted (shTDP2) MCF7 cells before and 30min after treatment with 20 µM etoposide, and after the
indicated repair periods in drug-free medium. Other details as in b. f The number of γH2AX foci in untransfected MCF7 cells or in mock-depleted (shControl)
or TDP2-depleted (shTDP2) MCF7 cells following incubation for the indicated times with 100 nM 17β-estradiol. Data are the mean (±s.e.m.) of ﬁve
independent experiments. Statistical signiﬁcance was determined by T-tests (*P< 0.05, **P< 0.01) and are comparisons with shControl cells. g Basal mRNA
levels of two ER-regulated genes (TFF1 & GREB2) and one ER-independent gene (TBP) in mock-depleted (shControl) or TDP2-depleted (shTDP2) MCF7 cells.
mRNA levels were quantiﬁed by qRT-PCR and normalized relative to ACTB levels under the same experimental conditions. The normalized value from TDP2
patient cells was then expressed relative to the normalized value from the mock-depleted control cells. Data are the mean (±s.e.m.) of three independent
experiments. Statistical signiﬁcance was determined by T-tests (*P< 0.05, ***P< 0.005, NS, not signiﬁcant)
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It is likely that cleavage complexes become abortive at
some frequency even in the absence of TOP2 poisons. Indeed,
TOP2-induced DSBs have been implicated in oncogenic trans-
location events not only in response to exposure to chemother-
apeutic TOP2 poisons, but also in the formation of de novo
translocations5, 10, 15. Consistent with this, cells possess DNA
repair enzymes with activities targeted speciﬁcally at removing
trapped topoisomerase activity from DNA 5′ termini, such as
tyrosyl-DNA phosphodiesterase 2 (TDP2)16–18. TDP2 cleaves
the phosphotyrosyl bond between the topoisomerase and the
5′ phosphate of the DNA generating ligatable ends that can
be processed by the non-homologous end-joining (NHEJ)
pathway18, 19. Here, we have addressed directly the impact of
TDP2-dependent repair of TOP2-induced DSBs on genome
stability and in chromosome translocations in human cells. We
show that TDP2 rejoins DSBs induced during transcription-
dependent TOP2 activity in breast cancer cells and at the
translocation ‘hotspot’, MLL. Moreover, we ﬁnd that
TDP2 suppresses chromosome rearrangements induced by TOP2
and reduces TOP2-induced chromosome translocations that arise
during gene transcription. Collectively, these data highlight the
threat posed by TOP2 in genome instability during gene
transcription and demonstrate the importance of TDP2-
dependent NHEJ for suppressing this instability.
Results
Human TDP2 suppresses TOP2-induced genome instability.
We previously reported that TDP2-dependent NHEJ is required
for genome stability in murine cells18. To determine whether
TDP2 is required to maintain genomic stability in human cells we
employed lymphoblastoid cells from a patient in which TDP2 is
mutated11. These cells lack detectable TDP2 activity, are deﬁcient
in the repair of TOP2 breaks, and are hypersensitive to TOP2
poisons11. TDP2 patient cells exhibited a signiﬁcantly greater
increase in micronuclei and nucleoplasmic bridges than did
normal control lymphoblastoid cell lines (LCLs) following
treatment with low doses of etoposide, suggesting that genome
instability is increased in the absence of TDP2 at sites of
TOP2-induced DSBs (Fig. 1a). To measure the impact of TDP2
on chromosome stability directly, we conducted M-FISH of ﬁxed
chromosome preparations (Fig. 1b). Although similar numbers of
abnormal metaphases were observed in control and TDP2 patient
cells in the absence of etoposide treatment, treatment with an
etoposide concentration that only slightly increased abnormal
metaphases in control cells increased abnormal metaphases
in TDP2 patient cells ~ ﬁvefold; from 0.14 per metaphase to
0.68 per metaphase. Moreover, TDP2 patient cells harbored on
average ~ 10-fold more chromosome aberrations per cell than did
control cells following etoposide treatment (Supplementary Fig. 1;
3.96 and 0.4 aberrations per cell, respectively). These were
comprised of both chromosome and chromatid-type events but
the latter were far more prevalent; increasing ~ 30-fold in
etoposide-treated TDP2 patient cells from 0.04 to 3.53 aberrations
per cell, compared with little or no increase in normal
cells (Supplementary Fig. 1). Notably, patient cell populations
exhibited a particularly high frequency of metaphases with
multiple aberrations, including complex events involving multiple
chromosomes (Fig. 1c). Collectively, these results demonstrate
that TDP2 is required to maintain chromosome stability
in human cells following the induction of DSBs by abortive
TOP2 activity.
TDP2 protects gene transcription from TOP2-induced DSBs.
Although TDP2 can promote repair of TOP2-induced DSBs
arising during S phase, we have proposed that the error-free
nature of this pathway may have particular utility in non-cycling
cells that lack alternative error-free pathways such as homologous
recombination repair18. Consequently, TDP2 may have particular
utility in removing TOP2-induced DSBs arising during
gene transcription, which can arise independently of cell cycle
status. To address this, we employed diploid human RPE-1
hTERT cells in which we disrupted TDP2 gene using CRISPR-
Cas9. TDP2−/− RPE-1 cells exhibited hypersensitivity to etopo-
side and a reduced rate of repair of etoposide-induced DSBs, as
measured using γH2AX immunofoci as a marker of DSBs20
(Fig. 2a, b). Importantly, in quiescent cells, the elevated accu-
mulation of etoposide-induced DSBs in TDP2−/− cells was
prevented by pre-incubation with the RNA polymerase II tran-
scription inhibitor DRB, suggesting that TDP2 is important for
the repair of TOP2-induced DSBs arising during transcription
(Fig. 2c).
TOP2 activity has been implicated previously in DSB induction
during hormone-regulated gene transcription9, 10. Consistent
with this, we showed previously that TDP2 is required to
maintain normal levels of TOP2-dependent gene transcription
stimulated by androgen11. To further address the role of TDP2 in
the repair of DSBs induced during transcription we depleted
TDP2 in the ER-positive breast cancer cell line MCF7 using anti-
TDP2 shRNA. TDP2-depleted MCF7 cells exhibited reduced DSB
repair following treatment with etoposide and correspondingly an
increase in hypersensitivity to this drug (Fig. 2d, e). Interestingly,
the addition of estradiol alone resulted in the accumulation
of γH2AX foci in MCF7 cells, and did so to a greater extent
in MCF7 cells depleted of TDP2 (Fig. 2f). More importantly,
both the basal level and estradiol-stimulated level of transcription
of TFF1 and GREB1, two genes known to be regulated by
estrogen, was reduced in TDP2-depleted MCF7 cells when
compared to wild-type MCF7 cells (Fig. 2g and Supplementary
Fig. 2). Collectively, these results implicate TDP2 in the removal of
TOP2-induced DSBs arising during gene transcription and in
the protection of transcription from inhibition by TOP2-induced
DSBs.
TDP2 protects MLL from TOP2-induced breakage. Next, we
investigated the impact of TDP2 on DNA breaks occurring at the
MLL chromosome locus, which are also associated with TOP2
activity. Translocations involving the breakpoint cluster region
(BCR) of MLL gene are amongst the most common chromosome
rearrangements observed in leukaemia7. Rearrangements of the
MLL gene can involve one of a large number of partners and are
implicated in both therapy-related acute leukemia and infant
acute leukaemia21. Numerous potential mechanisms for MLL
translocation have been proposed, including nucleases involved in
VDJ recombination, Alu-mediated recombination, apoptotic
nucleases, and TOP2-induced breaks7, 15. To examine whether
TDP2 is required to protect MLL from TOP2-induced breakage,
we employed FISH probes ﬂanking this locus so that we could
detect etoposide-induced breaks via their impact on the spatial
proximity of these probes (Fig. 3a).
The addition of etoposide increased to ~ 10% the fraction
of wild-type RPE-1 cells harboring a visible break at one of the
two MLL loci (Fig. 3a). More importantly, this fraction increased
to ~ 30% in TDP2−/− RPE-1 cells, implicating TDP2 in the repair
of TOP2-induced DSBs at MLL. Similar results were observed in
lymphoblastoid cells, in which etoposide-induced more MLL
breaks in TDP2 patient cells than in control cells (Fig. 3b). The
breaks detected in these experiments were not apoptotic breaks22,
because we did not detect any evidence for signiﬁcant apoptosis
under the conditions employed (Supplementary Fig. 3). Impor-
tantly, the presence of elevated etoposide-induced breaks at MLL
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in the absence of TDP2 was also observed in quiescent cells,
consistent with the source of these breaks being TOP2 activity
during transcription rather than DNA replication (Fig. 3c).
Indeed, consistent with this, pre-incubation with the transcription
inhibitor DRB greatly reduced or ablated theMLL breaks detected
by FISH in both wild-type and TDP2−/− RPE-1 cells (Fig. 3a, c).
The impact of DRB did not reﬂect an inﬂuence on cell
cycle distribution23, because we did not observe any impact of
DRB in this respect (Supplementary Fig. 3). Finally, to conﬁrm
that the role of TDP2 in preventing MLL breakage required its
catalytic activity we compared recombinant wild-type TDP2 and
catalytic mutant TDP216, 17 for ability to complement this
defect in TDP2−/− RPE-1 cells. Indeed, whereas wild-type
TDP2 signiﬁcantly reduced TOP2-induced MLL breakage,
mutant TDP2 did not (Fig. 3d).
Collectively, these data indicate a role for TDP2 activity in the
repair of TOP2-induced DSBs generated during gene transcrip-
tion at the breakpoint cluster region ofMLL; a chromosome locus
that is a hotspot for oncogenic translocations.
TDP2 suppresses TOP2-induced chromosome translocations.
To examine directly the impact of TDP2 on the frequency of
TOP2-induced chromosome translocations we again employed
FISH. Wild-type and TDP2−/− RPE-1 cells were maintained
in G0/G1 during and following treatment with etoposide, to
avoid the impact of TOP2-induced DSBs arising during DNA
replication, and then released into cell cycle to enable the
detection of translocations involving chromosome 8 or 11 by
whole-chromosome FISH (Supplementary Fig. 4) Translocations
were observed in both cell lines following etoposide treatment but
were ~ 4 times more frequent in TDP2−/− RPE-1 cells, indicating
that TDP2 suppresses the formation of chromosome transloca-
tions induced by TOP2 (Fig. 4a). Importantly, the translocations
associated with loss of TDP2 were prevented by pre-incubation
with DRB, implicating gene transcription by RNA polymerase II
as the source of the TOP2-induced DSBs that resulted in trans-
location (Fig. 4a). Notably, expression of wild-type recombinant
TDP2 but not the catalytic mutant TDP2 reduced the frequency
of translocations in TDP2−/− cells (Fig. 4b). These results indicate
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Fig. 3 TDP2 is required for the repair of TOP2-induced DSBs at MLL. a Detection of brokenMLL loci by FISH in wild-type and TDP2−/− RPE-1 cells following
mock-treatment or treatment with 100 µM etoposide for 6 h. Where indicated, cells were pre-incubated with DRB (100 µM) for 3 h prior to etoposide
treatment. Left, representative images of intact (yellow) and broken (red and green)MLL loci (Scale bar 5 µm). The position of the FISH probes (red and green
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signiﬁcance was measured by T-tests (*P< 0.05, **P< 0.005, ***P< 0.001). b Detection of broken MLL loci in normal and TDP2 patient lymphoblastoid
cells, measured as above. Data are the mean (± s.e.m.) of two independent experiments. c Detection of broken MLL loci by FISH in serum-starved
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was determined by T-tests (*P< 0.05,**P< 0.005, NS, not signiﬁcant). c Circos plot showing the genomic distribution of MLL translocation partners
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junction sequences of etoposide-induced MLL translocations with 4-bp (top) or <4-bp regions of junction homology (bottom three). Right, distribution
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We propose that the latter events are rare but result in a translocation with 4-bp of junction homology. Right, in the absence of TDP2, processing of
5′-phosphotyrosine termini requires nuclease activity and consequently error-prone NHEJ resulting in microdeletions (if the correct adjacent termini
are rejoined) or translocations (if incorrect distal termini are joined) with ≠ 4-bp of junction homology
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that TDP2 activity suppresses TOP2-induced translocations
during gene transcription.
To analyze the nature and sequence of the translocations
induced by TOP2 in the presence and absence of TDP2 we
employed inverse PCR to amplify the breakpoint cluster region
(BCR) of MLL (Supplementary Fig. 5). Etoposide treatment
increased the appearance of PCR products that were different in
size from that expected for wild-type product, suggesting that we
had successfully isolated translocation breakpoints (Supplemen-
tary Fig. 5). Of a total of forty-three different MLL translocation
breakpoints that we isolated, 84% involved partner loci that were
located in actively transcribed regions, consistent with transcrip-
tion stimulating theMLL translocations (Supplementary Table 2).
Interestingly, 26% of theMLL translocation partners were present
in the same or adjacent cytogenetic chromosome bands as MLL
(Fig. 4c). This is in agreement with the notion that physical
proximity greatly inﬂuences the choice of translocation partner3.
We failed to detect a signiﬁcant variation between wild-type and
TDP2−/− cells in the distribution ofMLL partners, suggesting that
TDP2 does not inﬂuence the site of TOP2-mediated cleavage
(Fig. 4c and Supplementary Table 2). Intriguingly, however,
Sanger sequencing of the translocation junctions suggested
that whereas some translocation events in wild-type cells involved
4 bp of identical sequence at the breakpoint in both MLL and
the translocation partner, these events were absent in TDP2−/−
cells (Fig. 4d). Thus, while TDP2 overall greatly suppresses
chromosome translocations at sites of TOP2 cleavage, it might
be responsible for a small subset of translocations that are
characterized by 4-bp of perfect homology at the translocation
junction.
Discussion
In this study we have addressed the impact of TDP2-dependent
DSB repair on chromosome rearrangements mediated by the
abortive activity of TOP2. M-FISH revealed that lymphoblastoid
cells from a TDP2-defective patient incur elevated chromosome
aberrations following the induction of TOP2-induced DNA
breaks by etoposide. These results are in agreement with previous
cytogenetic analyses of lymphoid tissue in etoposide-treated
Tdp2−/− mice18. Chromatid-type breaks were particularly pre-
valent in etoposide-treated TDP2 patient cells, consistent with the
high level of TOP2 activity associated with chromosome dupli-
cation during S/G2-phase24.
Another major source of genome instability and tumorigenesis
are DSBs that arise during gene transcription, which can result in
chromosome translocations. However, the origins of these DSBs
and the molecular processes by which they result in transloca-
tions are unclear. Here, we have shown that TDP2 suppresses
transcription-associated DSBs induced by TOP2 and prevents
the accumulation of DSBs arising during estrogen stimulation.
It is currently unclear whether the estrogen-induced breaks in
TDP2-defective cells reﬂected estrogen-stimulated transcription
or estrogen-stimulated entry into S phase. However, the former
possibility is consistent with the requirement for TDP2 for
normal levels of androgen-driven transcription in prostate
cancer cells11. Indeed, in the current study, TDP2-depleted cells
exhibited reduced expression of estrogen-regulated genes in
breast cancer cells, suggesting that TDP2 does indeed protect
estrogen-regulated gene transcription from inhibition by TOP2-
induced DSBs.
Strikingly, TDP2 also prevented the accumulation of etoposide-
induced DSBs within the breakpoint cluster region of the mixed
lineage leukemia (MLL) locus. These observations have important
implications for carcinogenesis because TOP2-induced DSBs are
strongly implicated in oncogenic translocations15, including those
arising at MLL10, 15. Moreover, based on whole-chromosome
FISH of chromosome 8 and 11, our results suggest that
TDP2 suppresses the frequency of etoposide-induced chromo-
some translocations genome-wide. Importantly, the translocation
events that were suppressed by TDP2 were almost entirely
transcription dependent. These data highlight both the threat
posed by abortive TOP2 activity to genome stability during
transcription and the importance of TDP2-dependent DSB repair
in suppressing TOP2-induced genome instability. It should be
noted, however, that we did not detect an impact of TDP2 on
genome instability in the absence of etoposide. This is consistent
with the similar lack of genome instability in Tdp2−/−mice, in the
absence of etoposide treatment. The apparent absence of genome
instability in TDP2−/− cells and mice at endogenous levels of
TOP2-induced DNA breakage most likely reﬂects the availability
of alternative mechanisms for removing TOP2 from DSB termini,
such as Mre11-dependent NHEJ and/or HR25.
Sequence analysis of the translocation junctions at MLL in our
experiments revealed that ~ 80% of the translocation partners
were transcriptionally active regions. Moreover, there was strong
bias towards translocation partners located on the same
chromosome as MLL, consistent with the proximity of TOP2-
induced DSBs inﬂuencing the likelihood of rejoining incorrect
chromosome termini. Since TDP2 activity generates DSB termini
that are ligated by the canonical pathway for cNHEJ18, our
discovery that TDP2 supresses the overall frequency of etoposide-
induced chromosome aberrations and translocations implicates a
protective role for NHEJ events involving TDP2 in genome sta-
bility. This is in contrast to DSBs induced by recombinant
nucleases, which in human cells implicate NHEJ in the formation
of chromosome translocations26. We propose that this difference
reﬂects the nature of the termini at the DSBs. In contrast to
most DSBs, those induced by TOP2 and processed by TDP2
result in 4-bp cohesive 5′-overhangs that enable the rapid ligation
of adjacent termini without further processing, thereby reducing
the chance of joining together incorrect termini19. This idea may
also explain our observation that a small subset of translocation
junctions involving 4-bp of perfect homology appeared to be
absent in TDP2−/− cells. We suggest that while adjacent 4-bp
cohesive DSB termini generated by TDP2 are normally correctly
re-ligated, on rare occasions these termini re-ligate incorrectly
with a distal TOP2-induced DSB harboring an identical 4-bp
sequence overhang. This type of junction has been reported for a
therapy-related MLL translocation in leukemia27, 28, and sug-
gested to arise by TOP2 domain swapping21, 29, 30. While further
work is required to conform this observation, our data suggest
that this class of translocation may result from TOP2-induced
DSBs processed by TDP2 (Fig. 4e). It is important to note,
however, that most of the TOP2-induced translocations arising in
wild-type and TDP2−/− RPE-1 cells either lacked homology at
the junction or harbored smaller regions of microhomology,
consistent with previous observations31 and with their generation
by TDP2-independent inaccurate NHEJ.
In summary, transcriptionally active loci are regions of the
genome commonly associated with translocations32, and often
these loci are associated with high levels of TOP2 activity9, 10, 12.
Our data demonstrate the threat posed by TOP2-induced DSBs to
gene transcription and genome stability, and highlight the role of
TDP2-dependent NHEJ in protecting transcription and genome
stability from these breaks.
Methods
Cell culture. Normal and TDP2 patient11 LCLs were maintained in RPMI
supplemented with 10% FCS and with penicillin and streptomycin. RPE-1 cells
(originally purchased from ATCC) were propagated in DMEM/F12 medium
supplemented with 10% FCS. TDP2−/− RPE-1 cells expressing wild-type human
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TDP2 or catalytic mutant TDP2D262A (TDP2CD) were generated using the
lentiviral vector pSIN-DUAL-GFP. Cells were sorted for GFP positivity before use,
and all experiments were performed in cultures with at least 70% of GFP-positive
cells. For serum starvation cells were grown until conﬂuency and then cultured
in 1% FCS for 5–8 days. All cell lines were grown at 37 °C, 5% CO2. For ER-
dependent gene induction cells were washed with serum-free medium three
times for 30 min and incubated in medium containing 5% charcoal-stripped
FBS for at least 48 h before experiment. Etoposide, 17β-estradiol (estradiol) and
5,6-dichlorobenzimidazole 1-β-D-ribofuranoside (DRB) were purchased from
Sigma. All cell lines were tested for mycoplasma contamination.
Western blotting. Anti-TDP2 antibody was employed at 1:5000 in western
blotting and has been described previously33. Anti-Actin (Sigma A4700) was
employed at 1 : 2000 and anti-Histone 1.2 (Abcam ab17677) at 1 : 20,000. Full blots
are included in Supplementary Fig. 6.
Generation of TDP2-depleted MCF7 cells and TDP2−/− RPE-1 cells. To stably
deplete TDP2, MCF7 cells were co-transfected with pcD2E vector and either
pSuper-TTRAP/TDP2 or pSuper as described previously16 and selected in 0.5 mg
ml−1 G418 to isolate single clones. To delete TDP2, we employed CRISPR-Cas934.
A 17-bp (minus the PAM) Tru-guide35 RNA sequence targeting TDP2 exon 1
(5′-GCGGCGACTTCTGTGTG-3′) was selected using the E-CRISP tool E-CRISP
(http://www.e-crisp.org/E-CRISP/) and cloned into the guide RNA vector #41824
(AddGene). Brieﬂy, the Tru-guide sequence minus the PAM were annealed and
extended into a 98-mer double-stranded fragment using Phusion polymerase
(NEB) which was then subcloned into the guide RNA vector using Gibson
Assembly (NEB)36. The TDP2 guide construct was co-transfected with hCas9
expressed from plasmid #41815 (AddGene) using a Neon electroporation system
(Invitrogen). Transfected cells were enriched by selection in 0.5 mg/ml G418
(Thermoﬁsher) for 5 days prior to isolation of single clones and screening for loss
of TDP2 expression by western blotting.
Clonogenic survival assays. Cells were plated in 10 mm plates and 3 h later
treated with indicated concentrations of etoposide for 1 h. Cells were rinsed twice
with PBS and incubated with fresh drug-free media for 10 days and then ﬁxed in
70% ethanol/1% methylene blue. The surviving fraction at each dose was calculated
by dividing the average number of colonies (>50 cells) in treated dishes by the
average number in untreated dishes.
Micronuclei and nucleoplasmic bridges. To detect micronuclei (MN) and
nucleoplasmic bridges (NB), cytochalasin B (Sigma) was added to cell cultures at 4
mgml−1. After 24 h, cells were ﬁxed and stained with DAPI.
Metaphase spreads. For metaphase spreads, cells were incubated with
demecolcine (Sigma) at 0.2 µg/ml for 4 h and then harvested. Cells were
collected using standard cytogenetic techniques and ﬁxed in 3 : 1 methanol:acetic
acid. Fixed cells were dropped onto acetic acid-humidiﬁed slides.
Immunoﬂuorescence and FISH analysis. For immunoﬂuorescence (IF), cells were
grown on coverslips for 2 days (for cycling cultures) or 8 days (for serum-starved
and conﬂuency-arrested cell cultures) and then treated as indicated. Cells were
ﬁxed (10 min in PBS-4% paraformaldehyde), permeabilized (2 min in PBS-0.2%
Triton X-100), blocked (30 min in PBS-5% BSA), and incubated with the indicated
primary antibodies for 1–3 h in PBS-1% BSA. Cells were then washed (3 × 5 min in
PBS-0.1% Tween 20), incubated for 30 min with the corresponding AlexaFluor-
conjugated secondary antibody (1 : 1000 dilution in 1% BSA-PBS) and washed
again as described above. Finally, cells were counterstained with DAPI (Sigma) and
mounted in Vectashield (Vector Labs). γH2AX foci were manually counted
(double-blind) in 20 to 40 cells per data point per experiment. For the analysis
of G0/G1 cells, only CENP-F negative cells were scored. Primary anti-γH2AX
(Millipore, 05-636) were employed at 1 : 1000 and anti-CENP-F (Abcam, ab5) at
1 : 500. FISH was performed according to manufaturer’s protocol (CytoCell). For
M-FISH, a modiﬁed version of Metasystems protocol was used. Chromosome and
chromatid aberrations were analyzed and categorized as exchanges or breaks.
Exchange type aberrations were further categorized as ‘simple’ (involving
maximum of two breaks in two chromosomes) or ‘complex’ (any exchange
involving >3 breaks)37.
Inverse PCR. For the detection of single chromosomal translocations an
adaptation of an inverse PCR protocol38 was performed. After treatment, genomic
DNA was extracted with the DNeasy Blood and Tissue Kit (Qiagen). 10 µg of DNA
were incubated for 1 h with Shrimp Alkaline Phosphatase (NEB). After inactivation
and digestion with either Bgl2 or Sac1 (NEB) DNA was puriﬁed with QIAquick
PCR Puriﬁcation Kit (Qiagen). To ensure ligation in cis of DNA molecules DNA
was diluted at 18 µg/ml and ligated for 20 h at 4 °C. After puriﬁcation and
quantiﬁcation 40ng of DNA were used per PCR reaction. Two consecutive
PCR reactions (LongAmp polymerase, NEB) were performed to ensure speciﬁc
ampliﬁcation. First-round primers: MLLBgl2_1: (5′-
GAGGAAATCAGCACCAACTGGGGGAA-3′) and MLLBgl2_2: (5′-
GATCCTGTGGACTCCATCT
GCTGGAA-3′) or MLLSac1_1 (5′-ATATGGGTGCAAAGCACTGTAT-3′) and
MLLSac1_2 (5′-ACCAGTCCTTCAACTTCTGGG-3′). One microliter of a 1 : 10
dilution of the ﬁrst-round PCR mix was ampliﬁed with second-round primers:
MLLBgl2_3: (5′-CATTAGCAGGTGGGTTTAGCGCTGGG-3′) and MLLBgl2_4:
(5′-TTCTCCTGCTTATTGACCGGAGGTGG-3′) or MLLSac1_3 (5′-CAGTA-
GACCCCTGGCACTTG-3′) and MLLSac1_4 (5′-AGCAATCTCACAGGGT
TCCT-3′). Novel-size bands were puriﬁed from agarose gel and sequenced using
MLLBgl2_4 or MLLSac1_5 (5′-AGTGCAGTGGCGTGATAATG-3′) primers.
Translocations were represented as by a Circos plot39 using the OmicCircos
package of R.
Data availability. All data are available from the authors on request.
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